A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL
Clinical trial NCT05365100 · WITHDRAWN
Trial details
- NCT number
- NCT05365100
- Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-07-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.